Topical tacrolimus neither prevents nor abolishes ultraviolet–induced erythema - 09/08/11
Bochum, Germany
Abstract |
A dose- and vehicle-controlled study on the pretreatment and posttreatment effect of 0.1% tacrolimus ointment on erythema induced by solar-simulated ultraviolet (UV) radiation was performed. Surprisingly, comparisons of clinical erythema scores and colorimetric data obtained 24 and 72 hours after UV exposure did not reveal significant differences between the control, tacrolimus, and vehicle preirradiation and postirradiation treated sites (P > .05). Our data strongly indicate that topical tacrolimus neither prevents nor abolishes UV–induced erythema in a clinical meaningful degree.
Le texte complet de cet article est disponible en PDF.Plan
Funding sources: None. Conflicts of interest: None identified. |
Vol 55 - N° 5
P. 882-885 - novembre 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?